Clinical use of drotrecogin alfa (activated): Patients treated in mercury differ from those in PROWESS.
Author Department
Medicine
Document Type
Presentations, Research
Publication Date
12-1-2003
Recommended Citation
Schmidt G, Bates B, Shwed McCollam J, Steingrub JS. Clinical use of drotrecogin alfa (activated): Patients treated in mercury differ from those in PROWESS. Society of Critical Care Medicine 34th Critical Care Congress. San Antonio, TX. Jan 28-Feb 2, 2003.
COinS